What are the rest of the AEMD team members doing?
Reading the iHub and IV posting for the last several months, I am impressed with all the investors’/posters’ initiatives and attempts to communicate with the various Federal agencies and scientific/medical community regarding Aethlon and the Hemopurifer.
Most of the board discussions revolve around what “JJ” is, or is not, doing. Then it dawned on me: “Doesn’t AEMD also have executive level staff that should be helping JJ carry on the fight and spread the good word about the Hemopurifier?”
Below is Yahoo Finance’s list AEMD’s “key executives” (Kenley, Frakes & Tullis) and their yearly compensation. Also listed below are the doctors and scientists on AEMD Scientific Advisory Board per AEMD’s website. (I’m not aware of their compensation.)
What are all these other team members doing to help the cause? Why does it appear that AEMD’s small-time investors are knocking themselves out in an attempt to get the scientific, medical and government communities to notice the Hemopurifier? Isn’t that something JJ’s well compensated staff should be doing for him and the company?
I appreciate any thoughts or insights anyone may have.
glasanderson
//////////////////////////////////////////////////////////////
Mr. Rodney S. Kenley , Pres and Director, $240,000
Mr. James B. Frakes , Chief Financial Officer and Sr. VP of Fin., $183,000
Dr. Richard H. Tullis Ph.D., Chief Scientific Officer, Sr. VP and Director; $195,000
The AEMD website currently lists the following members of its “Scientific Advisory Board’
Gregory T. A. Kovacs, M.D., Ph.D.
John A. Kellum, M.D.
Nathan W. Levin, M.D.
Claudio Ronco, M.D.
David M. Ward, M.D.
Stephen Z. Fadem, M.D.
Irshad H. Chaudry, Ph.D.
Larry D. Cowgill, D.V.M., Ph.D.
Charles J. Fisher, Jr., M.D.
Geert Schmid-Schönbein, Ph.D.
Laszlo Radvanyi, Ph.D.
